0.225
0.015 (7.14%)
0.015 (7.14%)
Upgrade to Real-Time
Market Open
| Volume | 134,030 |
|
|||||
| News | - | ||||||
| Day High | 0.229 | Low High |
|||||
| Day Low | 0.1952 | ||||||
Best deals to access real time data! |
|
Small Cap Basic
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Oncotelic Therapeutics Inc (QB) | OTLC | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.015 | 7.14% | 0.225 | 12:46:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1998 | 0.1952 | 0.229 | 0.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 28 | 134,030 | $ 0.211236 | $ 28,312 | - | 0.0805 - 0.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:46:32 | 2,500 | $ 0.225 | USD |
Period:
Draw Mode:
Oncotelic Therapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 84.96M | 377.61M | 170.97M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 8.61k | $ - | - | - | - |
Oncotelic Therapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.22 | 0.235 | 0.1503 | 0.2023288 | 98,110 | 0.005 | 2.27% |
| 1 Month | 0.235 | 0.235 | 0.1503 | 0.2208499 | 110,924 | -0.01 | -4.26% |
| 3 Months | 0.22 | 0.259 | 0.1503 | 0.2315461 | 115,432 | 0.005 | 2.27% |
| 6 Months | 0.13 | 0.259 | 0.0805 | 0.1801494 | 186,594 | 0.095 | 73.08% |
| 1 Year | 0.31 | 0.34 | 0.0805 | 0.1689827 | 189,388 | -0.085 | -27.42% |
| 3 Years | 0.24 | 0.36 | 0.0805 | 0.1861736 | 194,525 | -0.015 | -6.25% |
| 5 Years | 0.24 | 0.36 | 0.0805 | 0.1861736 | 194,525 | -0.015 | -6.25% |
Oncotelic Therapeutics (QB) Description
| Oncotelic Therapeutics, Inc. (OTLC) are developing three lines of therapeutics. 1) Oncology/Virology - we are developing OT-101 (TGF-beta antisense/ Artemisinin) and VDA agents (Oxi4503/CA4P) against viral infections and various tumors including three rare pediatric tumors (DIPG, Melanoma, and AML). The program is being funded by our partner GMP through a JV that we are intend to take IPO. 2) AL-101 (intranasal-apomorphine) for the treatment of Parkinson Disease, Erectile Dysfunction not responding to PDE5 inhibitor, and Female Sexual Dysfunction. 3) Animal health product including oncology (CA4P and Artemishas). |